Robert Azelby
Affiliations
- Director at Cardinal Health Inc (CAH), 2024-03-18
- Director at Adc Therapeutics Sa (ADCT), 2024-01-03
- Director at Chinook Therapeutics Inc. (KDNY), 2023-08-11
- President & Ceo at Eliem Therapeutics Inc. (ELYM), 2022-11-02
- Director at Clovis Oncology Inc. (CLVS), 2021-06-12
- Director at Immunomedics Inc (IMMU), 2020-10-23
- President And Ceo at Alder Biopharmaceuticals Inc (ALDR), 2019-10-24
- Director at Cascadian Therapeutics Inc. (CASC), 2018-03-13
- Evp & Chief Commercial Officer at Juno Therapeutics Inc. (JUNO), 2018-03-07
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| JUNO | $85.55 | 4,159 | Officer | 89,612 | 2018-02-12 | Filing | |
| JUNO | $85.55 | 4,157 | Officer | 89,614 | 2018-02-12 | Filing | |
| JUNO | $85.77 | 3,497 | Officer | 93,771 | 2018-02-08 | Filing | |
| JUNO | $85.78 | 4,167 | Officer | 96,471 | 2018-02-01 | Filing | |
| JUNO | $86.25 | 102,539 | Officer | 70,832 | 2018-01-22 | Filing |